Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +65.4% | +50.5% | 2 / 3 | +49.6% | +0.32 pp | +0.17 pp | +19.1% | 2.01 | 5.71 | 841 | +49,6% | 14,7 | +65,4% | 5.71 | 8.35 | −31,6% |
| Pts | 12 | 12 | 8 | 12 | 8 | 8 | 8 | -4 | 12 | |||||||
Valuation annotation:Price: 17.400 (close price on 2026-10-19)EPS (TTM): 3.046
Financial charts
1.Revenue & growth
VND bn841Q2/26
1.Revenue & growth
VND bn841Q2/26
2.Profit & growth
VND bn14,7Q2/26
3.Profit mix (Penman)
VND bn43,7Q2/26
4.Margins & cost structure
%5.4%Q2/26
5.Returns & cash cycle
% · days23.1%Q2/26
6.Earnings quality & cash
VND bn95,9Q2/26
7.Asset structure
VND bn1.415Q2/26
8.Funding & debt health
VND bn · times1.415Q2/26
9.Revenue backlog
VND bn323Q2/26
10.Valuation
times · %6,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.178Q2/26
Adjusted EPS growth, latest quarter
65.4%
Average adjusted EPS growth, 3 quarters
50.5%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26